Holdings of the Fund as of 11/2/2026
Total Number of Holdings (excluding cash): 30
| Genmab A/S (ADR) |
GMAB |
372303206 |
Health Care |
2,689,156 |
$147,688,447.52 |
4.79% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Health Care |
133,530 |
$128,357,047.80 |
4.17% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Health Care |
1,665,333 |
$116,789,803.29 |
3.79% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Health Care |
902,796 |
$116,415,544.20 |
3.78% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Health Care |
659,437 |
$112,321,904.21 |
3.65% |
| Amgen Inc. |
AMGN |
031162100 |
Health Care |
240,285 |
$111,840,653.25 |
3.63% |
| Alkermes Plc |
ALKS |
G01767105 |
Health Care |
2,454,740 |
$110,193,278.60 |
3.58% |
| Biogen Inc. |
BIIB |
09062X103 |
Health Care |
441,660 |
$109,977,756.60 |
3.57% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Health Care |
181,527 |
$108,213,690.51 |
3.51% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Health Care |
195,436 |
$108,105,423.40 |
3.51% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Health Care |
1,800,381 |
$107,932,840.95 |
3.50% |
| Veracyte, Inc. |
VCYT |
92337F107 |
Health Care |
2,204,004 |
$107,996,196.00 |
3.50% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Health Care |
9,622,298 |
$106,422,615.88 |
3.45% |
| Incyte Corporation |
INCY |
45337C102 |
Health Care |
883,828 |
$106,094,713.12 |
3.44% |
| argenx SE (ADR) |
ARGX |
04016X101 |
Health Care |
120,828 |
$105,720,875.16 |
3.43% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Health Care |
1,819,273 |
$104,499,041.12 |
3.39% |
| BeOne Medicines Ltd. (ADR) |
ONC |
07725L102 |
Health Care |
281,229 |
$101,599,600.83 |
3.30% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Health Care |
699,850 |
$101,723,197.50 |
3.30% |
| NeoGenomics, Inc. |
NEO |
64049M209 |
Health Care |
6,097,063 |
$100,540,568.87 |
3.26% |
| Bio-Techne Corporation |
TECH |
09073M104 |
Health Care |
1,375,750 |
$99,975,752.50 |
3.24% |
| Tarsus Pharmaceuticals, Inc. |
TARS |
87650L103 |
Health Care |
1,362,589 |
$99,905,025.48 |
3.24% |
| Repligen Corporation |
RGEN |
759916109 |
Health Care |
573,309 |
$99,153,791.55 |
3.22% |
| Bruker Corporation |
BRKR |
116794108 |
Health Care |
1,694,205 |
$94,350,276.45 |
3.06% |
| Natera, Inc. |
NTRA |
632307104 |
Health Care |
248,778 |
$94,266,959.76 |
3.06% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Health Care |
211,312 |
$91,108,225.37 |
2.96% |
| BioNTech SE (ADR) |
BNTX |
09075V102 |
Health Care |
1,028,123 |
$89,991,606.19 |
2.92% |
| Illumina, Inc. |
ILMN |
452327109 |
Health Care |
358,368 |
$81,199,021.44 |
2.64% |
| Axsome Therapeutics, Inc. |
AXSM |
05464T104 |
Health Care |
592,143 |
$80,537,369.43 |
2.61% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Health Care |
428,429 |
$67,691,782.00 |
2.20% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Health Care |
822,569 |
$66,183,901.74 |
2.15% |
| US Dollar |
$USD |
|
Other |
4,517,859 |
$4,517,858.54 |
0.15% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|